ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,77%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,695
-0,11%
Bitcoin
64 865,82
-0,42%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Synlogic Inc (SYBX)

  7. Synlogic Inc (SYBX) Actualités

SYBX Synlogic Inc

1,55
-0,04 (-2,52%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Synlogic Inc SYBX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,04 -2,52% 1,55 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,57 1,52 1,59 1,55 1,59
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/5/202401:44EDGAR2Form SC 13D/A - General statement of acquisition of..
14/5/202413:00GLOBESynlogic Reports First Quarter 2024 Financial Results
14/5/202412:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202412:30EDGAR2Form 8-K - Current report
19/3/202412:00GLOBESynlogic Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202422:37EDGAR2Form 8-K - Current report
20/2/202423:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
20/2/202422:06EDGAR2Form 8-K - Current report
20/2/202418:15GLOBESynlogic Adopts Limited Duration Stockholders Rights Plan
16/2/202422:54EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202422:44EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202421:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202422:00EDGAR2Form 8-K - Current report
08/2/202422:15GLOBESynlogic Announces Decision to Discontinue Synpheny-3 Study..
02/2/202418:00GLOBESynlogic Announces Publication of Preclinical and Clinical..
04/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:00GLOBESynlogic Provides Corporate Update and Outlook for 2024
29/12/202322:00EDGAR2Form 8-K - Current report
27/12/202313:00GLOBESynlogic Announces Contract with the Air Force Research Lab
07/12/202313:00GLOBESynlogic Announces Abstract Accepted for Poster Presentation..
17/11/202322:00EDGAR2Form 8-K - Current report
15/11/202301:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202301:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202301:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:00GLOBESynlogic Reports Third Quarter 2023 Financial Results and..
09/11/202312:44EDGAR2Form 8-K - Current report
09/11/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00GLOBESynlogic Achieves Research Milestone and Earns $2.5 Million..
07/11/202312:45EDGAR2Form 8-K - Current report
13/10/202322:17EDGAR2Form SC 13D/A - General statement of acquisition of..
03/10/202322:15GLOBESynlogic Announces Closing of $21.0 Million Underwritten..
02/10/202323:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/9/202314:53EDGAR2Form 8-K - Current report
29/9/202313:00GLOBESynlogic Announces Pricing of $21.0 Million Underwritten..
29/9/202303:43EDGAR2Form S-1MEF - Registration adding securities to prior Form..
28/9/202322:15EDGAR2Form 8-K - Current report
28/9/202317:15GLOBESynlogic Announces Publication of Synpheny-1 Phase 2 Study..
28/9/202314:39EDGAR2Form S-1/A - General form for registration of securities..
27/9/202318:30GLOBESynlogic Announces Reverse Stock Split
27/9/202303:41EDGAR2Form S-1/A - General form for registration of securities..
22/9/202322:15EDGAR2Form 8-K - Current report
21/9/202313:00GLOBESynlogic to Participate in Chardan’s Genetic Medicines..
19/9/202317:00GLOBESynlogic Announces CEO Aoife Brennan Named to PharmaVoice..
08/9/202322:06EDGAR2Form S-1 - General form for registration of securities under..
01/9/202314:00EDGAR2Form DEF 14A - Other definitive proxy statements
21/8/202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
16/8/202322:05EDGAR2Form 8-K - Current report
10/8/202313:00GLOBESynlogic Reports Second Quarter 2023 Financial Results and..
10/8/202312:35EDGAR2Form 8-K - Current report
10/8/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
SYBX
Synlogic
NASDAQ
EXA
COIN
BNBBUSD
BNB
BIT
P1TVX9
NLBNPIT1TVX9 20240621 65
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés